Trinity Biotech produced something of a curate’s egg last week when it announced a 27 per cent increase in earnings per share in its quarter-three results.
The diagnostics company has earnings per share of $0.14 in the quarter, up over a quarter on the same period in 2005, and up by 18 per cent on the second quarter of 2006.
The result was 4 per cent ahead of the estimate set by Goodbody Stockbrokers but below the $0.15...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team